Dorsey Wright & Associates Compugen LTD Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$12.07 - $17.95 $18,008 - $26,781	-1,492 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$14.16 - $19.45 $7,051 - $9,686	-498 Reduced 25.03%	1,492 $24,000
Q1 2020 Apr 20, 2020	SELL	$5.79 - $11.83 $596 - $1,218	-103 Reduced 4.92%	1,990 $14,000
Q4 2019 Jan 31, 2020	BUY	$3.9 - $6.16 $8,162 - $12,892	2,093 New	2,093 $12,000

13.4M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $159M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.